Peptide record

TPDB10852

Latarcin 2a Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10852
Latarcin 2a
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 SATPdb dbACP AFP-GFuse Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 26-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFGKLIKKFGRKAISYAVKKARGKH
Physicochemical Analysis
C136H229N41O29
NDCEQMPTW
K
2902.57
11.77
10
0
11
+9
4.30
-0.438
82.69
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
51.33
2
Residue Composition
number
3
A
2
R
0
N
0
D
0
C
0
E
0
Q
4
G
1
H
2
I
2
L
7
K
0
M
2
F
0
P
1
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 1 I: 2 L: 2 K: 7 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
26
C136H229N41O29
2902.57
11.77
+9
4.30
-0.438
Free
L
Linear
Free
Antimicrobial
Central Asian spider, Lachesana tarabaevi
Evidence Records 24 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.5-0.7 µM

Target

Escherichia coli DH1

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P
Evidence 2 Activity

Activity

MIC
Antibacterial
6.7 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP

Other

Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S.
Evidence 3 Activity

Activity

MIC
Antibacterial
0.4-0.7 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 4 Activity

Activity

MIC
Antibacterial
6.7 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP

Other

), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 5 Activity

Activity

MIC
Antibacterial
54 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP

Other

uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 6 Activity

Activity

graph fig 8 A
Anticancer

Target

Breast Cancer
Breast tumor cellline
Breast

Assay & Model

LDH leakage assay
Not Available

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 7 Activity

Activity

MIC
Antifungal
0.5-0.7 µM

Target

Escherichia coli DH1

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P
Evidence 8 Activity

Activity

MIC
Antifungal
6.7 µM

Target

Pseudomonas aeruginosa

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S.
Evidence 9 Activity

Activity

MIC
Antifungal
0.4-0.7 µM

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 10 Activity

Activity

MIC
Antifungal
6.7 µM

Target

P. pastoris

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 11 Activity

Activity

MIC
Antifungal
54 µM

Target

S. cerevisiae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 12 Activity

Activity

MIC
Antiparasitic
0.5-0.7 µM

Target

Escherichia coli DH1

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P
Evidence 13 Activity

Activity

MIC
Antiparasitic
6.7 µM

Target

Pseudomonas aeruginosa

Source & Reference

DRAMP

Other

Active against Gram- E. coli DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S.
Evidence 14 Activity

Activity

MIC
Antiparasitic
0.4-0.7 µM

Target

B. subtilis

Source & Reference

DRAMP

Other

DH5alpha, E. coli DH1 (MIC 0.5-0.7 uM), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 15 Activity

Activity

MIC
Antiparasitic
6.7 µM

Target

P. pastoris

Source & Reference

DRAMP

Other

), P. aeruginosa (MIC 6.7 uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 16 Activity

Activity

MIC
Antiparasitic
54 µM

Target

S. cerevisiae

Source & Reference

DRAMP

Other

uM), Gram+ A. globiformis, B. subtilis (MIC 0.4-0.7 uM), yeasts P. pastoris (MIC 6.7 uM), S. cerevisiae (MIC 54 uM).
Evidence 17 Activity

Activity

% Hemolysis
Hemolysis
20 %
[Ref.16735513]20% hemolytic activity at 6 µM against rabbit erythrocytes

Target

rabbit erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
J Biol Chem. 2006 Jul 28 281(30):20983-20992.##Biochemistry. 2006 Sep 5 45(35):10759-10767.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 18 Activity

Activity

20% Hemolysis
Toxicity
6.0 µM
Hemolytic Cytotoxic
20% Hemolysis | 6.0 | µM | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity. | J Biol Chem | 2006
Evidence 19 Activity

Activity

50% Hemolysis
Toxicity
6 µM
Hemolytic Cytotoxic
50% Hemolysis | 6 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. | FEBS Lett | 2009
Evidence 20 Activity

Activity

50% Cell death
Toxicity
18 µM
Cytotoxic
50% Cell death | 18 | µM | target cell: Human leukocytes

Target

Human leukocytes

Source & Reference

NA
DBAASP
N-terminal amphipathic helix as a trigger of hemolytic activity in antimicrobial peptides: a case study in latarcins. | FEBS Lett | 2009
Evidence 21 Activity

Activity

100% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
100% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Membrane Interactions of Latarcins: Antimicrobial Peptides from Spider Venom | Int J Mol Sci | 2021
Evidence 22 Activity

Activity

40% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
40% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Potent antimicrobial peptides with selectivity for Bacillus anthracis over human erythrocytes. | Int J Antimicrob Agents | 2011
Evidence 23 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.16735513]20% hemolytic activity at 6 µM against rabbit erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
J Biol Chem. 2006 Jul 28 281(30):20983-20992.##Biochemistry. 2006 Sep 5 45(35):10759-10767.
Evidence 24 Hemolysis

Activity

20 %
% Hemolysis
[Ref.16735513]20% hemolytic activity at 6 µM against rabbit erythrocytes
Hemolysis

Target

rabbit erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
J Biol Chem. 2006 Jul 28 281(30):20983-20992.##Biochemistry. 2006 Sep 5 45(35):10759-10767.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.